Clinical Trials Browser

INDUSTRY × Glioblastoma × DOXO-EMCH × Clear all

NCT02014844 2024-05-29

Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma

Phase 2 Completed

28 enrolled 10 charts

Brain Neoplasms, Glioblastoma